Enthusiasm is Building for a Liquid Biopsy That May Replace Bone Marrow Biopsies
source: pixabay.com

Enthusiasm is Building for a Liquid Biopsy That May Replace Bone Marrow Biopsies

  BioFluidica recently issued an announcement that put the spotlight on its patented technology, Liquid Scan®. The new cartridge technology is designed to replace the invasive and painful bone marrow…

Continue Reading Enthusiasm is Building for a Liquid Biopsy That May Replace Bone Marrow Biopsies
ICYMI: Researchers Explore the Correlation Between Diabetic Retinopathy and Cardiovascular Disease
source: pixabay.com

ICYMI: Researchers Explore the Correlation Between Diabetic Retinopathy and Cardiovascular Disease

  According to a recent article in Medscape News, myocardial infarction (coronary artery blockage) and cerebrovascular incidents (stroke) have a direct correlation to diabetic retinopathy. The risk doubles when the…

Continue Reading ICYMI: Researchers Explore the Correlation Between Diabetic Retinopathy and Cardiovascular Disease

Enrollment Begins in Trial of Duchenne Muscular Dystrophy Treatment

According to BioSpace, the first patient has been enrolled in a trial of pamrevlumab, a Duchenne muscular dystrophy treatment. The third phase of LELANTOS plans to evaluate the drug's effects…

Continue Reading Enrollment Begins in Trial of Duchenne Muscular Dystrophy Treatment
BLA for Evinacumab, a Treatment for HoFH, Receives Priority Review Status
source: pixabay.com

BLA for Evinacumab, a Treatment for HoFH, Receives Priority Review Status

  This week, Regeneron Pharmaceuticals announced that their Biologics License Application (BLA) for evanicumab, a treatment for homozygous familial hypercholesterolemia (HoFH), was granted Priority Review status by the FDA. The…

Continue Reading BLA for Evinacumab, a Treatment for HoFH, Receives Priority Review Status
Mantle Cell Lymphoma: New Approaches are “Exploding,” Doctor Says
source: pixabay.com

Mantle Cell Lymphoma: New Approaches are “Exploding,” Doctor Says

According to a story from curetoday.com, patients living with mantle cell lymphoma, a rare form of blood cancer that makes up only around six percent of diagnosed non-Hodgkin lymphoma cases…

Continue Reading Mantle Cell Lymphoma: New Approaches are “Exploding,” Doctor Says
ICYMI: Phase 3 Study for Dermatomyositis has Completed Enrollment
source: pixabay.com

ICYMI: Phase 3 Study for Dermatomyositis has Completed Enrollment

Corbus Pharmaceuticals has just announced that participant enrollment for their Phase 3 trial of lenabasum for dermatomyositis has been completed. Dermatomyositis Dermatomyositis (DM) is a rare autoimmune disease. It can…

Continue Reading ICYMI: Phase 3 Study for Dermatomyositis has Completed Enrollment
Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients
source: pixabay.com

Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients

by Danielle Bradshaw from In The Cloud Copy Information provided by the Michael J. Fox Foundation showed that the majority of patients that had Parkinson’s disease and also contracted COVID-19…

Continue Reading Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients
ICYMI: Researchers Explore the Correlation Between Diabetic Retinopathy and Cardiovascular Disease
source: pixabay.com

ICYMI: Researchers Explore the Correlation Between Diabetic Retinopathy and Cardiovascular Disease

  According to a recent article in Medscape News, myocardial infarction (coronary artery blockage) and cerebrovascular incidents (stroke) have a direct correlation to diabetic retinopathy. The risk doubles when the…

Continue Reading ICYMI: Researchers Explore the Correlation Between Diabetic Retinopathy and Cardiovascular Disease
Close Menu